MARK C. MILLER - 07 Mar 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Director
Signature: /s/ Steven Reichling, attorney-in-fact
Issuer symbol: AXDX
Transactions as of: 07 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 09 Mar 2023, 15:24:53 UTC
Previous filing: 02 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXDX	Common Stock	Options Exercise	$0	+50,886		$0.000000	50,886	07 Mar 2023	Direct	F1
transaction	AXDX	Common Stock	Options Exercise	$0	+4,396	+8.6%	$0.000000	55,282	07 Mar 2023	Direct	F2
holding	AXDX	Common Stock						39,062	07 Mar 2023	By Mark C. Miller Trust, dated April 26, 2002

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Employee Restricted Stock Units	Options Exercise	$0	-50,886	-100%	$0.000000^*	0	07 Mar 2023	Common Stock	50,886		Direct	F1
transaction	AXDX	Employee Restricted Stock Units	Options Exercise	$0	-4,396	-100%	$0.000000^*	0	07 Mar 2023	Common Stock	4,396		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the "Vesting Date"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. This reporting person received a prorated amount of 50,886 RSUs, which is eight of the twelve months.
F2	The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 4,396 RSUs. All of the RSUs vested on the first-year anniversary of the Date of Grant. These RSUs are subject to the Company's Director Equity Deferral Program and were released within 30 days of separation from service.

Content

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the "Vesting Date"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. This reporting person received a prorated amount of 50,886 RSUs, which is eight of the twelve months.

The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 4,396 RSUs. All of the RSUs vested on the first-year anniversary of the Date of Grant. These RSUs are subject to the Company's Director Equity Deferral Program and were released within 30 days of separation from service.